tiprankstipranks
Trending News
More News >

JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited

Story Highlights
JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited

Confident Investing Starts Here:

An announcement from Mesoblast Limited ( (AU:MSB) ) is now available.

JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Mesoblast Limited, a company involved in the biopharmaceutical industry. This change in holding reflects a series of transactions involving the purchase, sale, and lending of securities, which resulted in a decrease in their voting power in the company.

The most recent analyst rating on (AU:MSB) stock is a Buy with a A$1.10 price target. To see the full list of analyst forecasts on Mesoblast Limited stock, see the AU:MSB Stock Forecast page.

More about Mesoblast Limited

Average Trading Volume: 6,028,786

Technical Sentiment Signal: Hold

Current Market Cap: A$2B

See more data about MSB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1